NCT04617522 2026-02-11Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver ImpairmentGilead SciencesPhase 1 Recruiting30 enrolled
NCT01452295 2013-12-04Registry Protocol for Tracking Trial Subjects After VTI-206 Study CompletionVital Therapies, Inc.Phase 2/3 Withdrawn